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Abstract Objective: Acute respi-
ratory tract infection is a common
reason for hospitalization in children
with Down syndrome (CDS) and is
characterized by a high morbidity.
The severe course of disease in CDS
may be related to a higher incidence
of acute lung injury (ALI). This study
evaluated the incidence of ALI and
acute respiratory distress syndrome
(ARDS) in mechanically ventilated
CDS. Design and setting: Retrospec-
tive cohort study in a pediatric ICU.
Patients and participants: Cases
were all mechanically ventilated CDS
admitted to our unit between January
1998 and July 2005. All mechanically
ventilated patients without Down syn-
drome from January 1998 to January
2001 served as controls. Postopera-
tive patients (cases and controls) and
those with a cardiac left to right shunt
were excluded. Measurements and
results: The main outcome measure
was the incidence of ALI and ARDS.
T h ec r i t e r i af o rA L Iw e r em e ti n1 4
of 24 CDS (58.3%) in 41 of 317 of
controls (12.9%; OR 9.4, 95% CI
3.9–22.6). The criteria for ARDS
were met in 11 of 24 CDS (46%) and
in 21 of317of controls (7%;OR 11.9,
95% CI 4.8–29.8). None of the CDS
with ALI died; in the control group
ten patients with ALI died. Conclu-
sions: CDS had a signiﬁcantly higher
incidence of ALI and ARDS than
children without Down syndrome.
The explanation for this remains to be
elucidated; further study is necessary
before clinical implications become
clear.
Keywords Acute respiratory dis-
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Introduction
Down syndrome (DS) is the most common chromosomal
abnormality and occurs in 1 of 800 live births [1]. Al-
though survival beyond the ﬁrst year of life has increased
considerably in recent decades, children with DS (CDS)
still have a shorter life expectancy than those without
DS [2]. Acute respiratory tract infection is a common
reason for hospitalization in CDS and is characterized
by high morbidity [3]. In children with DS it has been
suggested to be related to pharyngeal incoordination
predisposing to aspiration in combination with concomi-
tant immunodeﬁciencies [4, 5]. High morbidity in CDS
with respiratory disease may also be related to a higher
incidence of acute lung injury (ALI). The aim of this study
was to evaluate the incidence of ALI and acute respiratory
distress syndrome (ARDS) in children with DS who were
admitted to the pediatric intensive care unit (PICU) and
needed mechanical ventilation. Preliminary data from this
study were presented at the 35th Congress of the Society
of Critical Care Medicine [6].
Methods
This study compared the occurrence of ALI/ARDS in
two groups of patients requiring mechanical ventilation
because of respiratory insufﬁciency. The ﬁrst group2180
Down syndrome Control group p
(n=24) (n=317)
Median age (months; range) 15.2 (0–127.2) 6.1 (0–217.7) 0.39 c
Males 14 (58.3%) 199 (62.8%) 0.67 d
Median PRISM II score (range) 13.5 (0–40) 9.0 (0–47) 0.19 c
Sepsis 3 (12.5%) 52 (16.4%) 0.78 e
Lower respiratory tract infection 18 (75%) 130 (41%) 0.001 d
Upper respiratory tract infection 1 (4.2%) 23 (7.3%) 0.96 e
Congenital heart disease 1 (4.2%) 22 (6.9%) 0.99 e
CNS disorders a 0 53 (16.7%) 0.04 e
Other b 1 (4.2%) 37 (11.7%) 0.50 e
a CNS disorders: convulsions, infections, asphyxia, contusion, cerebral hemorrhage; b Others,e . g . ,
trauma, cardiomyopathies, electrolyte disturbances, metabolic disease; c Mann–Whitney test; d Pear-
son’s χ2 test; e Fisher’s exact test
Table 1 Baseline patient
characteristics and cause for
respiratory failure
consisted of all 24 consecutive children with genetically
conﬁrmed DS admitted to our PICU for mechanical
ventilation between January 1998 and July 2005. The
second group consisted of all 317 mechanically ventilated
children without DS admitted to our PICU between
January 1998 and January 2001. Baseline characteristics
for CDS and the control group are shown in Table1. The
PICU at Emma Children’s Hospital is a 16-bed, tertiary,
multidisciplinary unit serving the greater Amsterdam area.
Data on the incidence rate of ALI/ARDS in the second
group have been published previously [7]. In both groups
patients who were admitted for postoperative care directly
following a surgical procedure, and those with a cardiac
left to right shunt were excluded. Patients were retro-
spectively evaluated for ALI/ARDS during the second
24h after admission according to the American–European
Consensus Conference criteria [8]. Gas exchange criteria
for ALI and ARDS were considered to be met if the
PaO2/FIO2 ratio was less than 40.0kPa for ALI and
less than 26.7kPa for ARDS in at least two consecutive
measurements (>8h apart). A radiologist blinded to
clinical information reviewed the chest radiographs for
the presence of bilateral inﬁltrates. The presence of left
heart failure was assessed based on echocardiographic
results and/or clinical information. Disease severity
on admission was expressed by the Pediatric Risk of
Mortality (PRISM) II score, which depends on diagnosis
and clinical parameters in the ﬁrst 24h of admission [9].
Sepsis was deﬁned as systemic inﬂammatory response
syndrome in the presence of clinical evidence for in-
fection. Lower respiratory tract infection was deﬁned as
clinical infection with radiological evidence of alveolar
consolidation. Upper respiratory tract infection was
deﬁned as infection of the oral and nasal airways, larynx,
trachea, and/or bronchi without signs of lower respiratory
tract infection.
The comparability of patient characteristics for both
groups was tested by means of a chi-square test or Fisher
exact test for dichotomous data and a Mann–Whitney
U test for continuous data that were not normally dis-
tributed. The association between DS and ALI/ARDS was
expressed as an odds ratio (OR) with 95% Conﬁdence
Interval (CI). Other well known cause for ALI/ARDS and
thus possible confounders for the incidence of ALI/ARDS
among CDS were identiﬁed [8, 10] and evaluated with bi-
variate logistic regression analysis. Statistical signiﬁcance
was set at 5%.
Results
The criteria for ALI were met in 14 of 24 CDS (58.3%)
and in 41 of 317 controls (12.9%;odds ratio 9.4, 95% con-
ﬁdenceinterval3.9–22.6).The criteriafor ARDSweremet
in11of24CDS (46%)andin21of317controls(7%;odds
ratio 11.9, 95% conﬁdence interval 4.8–29.8). There were
nodeathsintheCDS. In thecontrolgrouptenpatientswith
ALI died during admission to the PICU. The results of the
logistic regression analyses are presented in Table2. The
odds for the incidence of ALI in CDS were hardly altered
by adjusting disease severity (PRISM II score), lower res-
piratory tract infection, or sepsis.
We excluded patients who died in the ﬁrst 24h after
admission. This might have caused a selection bias. There-
fore PICU deaths during the ﬁrst 24h of admission were
analyzed for ALI/ARDS: 36 in the control group, none of
whommettheALI/ARDScriteria.NoCDSdiedintheﬁrst
24h after admission. Thus the odds of developing ALI in
CDS are about9 times thosein controls, and this cannotbe
attributed to the presence of confounders.
Table 2 Estimated odds ratio (OR) for ALI (Down/control) after ad-
justment for possible confounders (CI, conﬁdence interval)
Possible confounder OR 95% CI
None 9.4 3.9–22.6
PRISM II score 9.6 3.9–23.6
Sepsis 12.2 4.9–30.6
Lower respiratory tract infection 10.8 4.3–26.92181
Discussion
This study found a very high incidence of 58% of ALI and
46% of ARDS in mechanically ventilated children with
DS. This is signiﬁcantly higher than the incidence of 13%
of ALI and 7% of ARDS in the general pediatric popula-
tion on mechanical ventilation in our unit. Likewise, Ran-
dolph et al. [11] reported an incidence of ARDS of almost
8% in a mechanically ventilated pediatric population.
The results of this study need to be interpreted with
caution due to the retrospective design and the relatively
low number of CDS. The results need to be conﬁrmed in
a prospective multicenter study in a larger cohort. Due to
the small number of CDS admitted annually to our unit
we included CDS for a longer period of time (1998–2005)
than the control group (1998–2001). This may interfere
with the comparability of the study groups. However,
medical care on our unit did not change substantially dur-
ing this extended period. In both study periods respiratory
care was based on the same clinical protocols with a low
tidal volume ventilation strategy. Identical ventilators were
used. In addition, the disease severity (expressed as mean
PRISM II scores) did not differ between 2001–2005 and
1998–2001. Therefore we have no reason to assume that
the incidence of ALI in mechanically ventilated patients
changed substantially during the 2001–2005 period.
Despite the high incidence of ALI/ARDS we found no
mortality in our population of CDS. Others have reported
a mortality rate of almost 5% in children with ARDS [11,
12]. Although this remains speculative, it is possible that
CDS aremoresusceptibletoprogressiontoALI/ARDS de-
spite less severe underlying conditions, without concomi-
tant mortality. In addition, there were only three patients
with sepsis and none with trauma as underlying cause of
ALI/ARDS in the CDS group, conditions associated with
a high mortality rate. However, ALI/ARDS is associated
with high morbidity in CDS. The need for ventilatory sup-
port was 21± 21days in CDS with ALI vs. 8± 5daysi n
CDS without ALI (p= 0.03). Long-term effects of ALI on
morbidity in CDS are unknown and remain to be deﬁned
by lung function measurements. The high mortality rate
among patients with ALI in the control group might be ex-
plained by the relatively high number of patients (n=4)
with severe cerebral damage. This has been shown to be
a strong predictor for mortality in ALI [13].
The mechanismleading to the highincidenceof ALI in
CDS remains uncertain. Initial ventilator settings have re-
cently been shown to be a risk factor for the development
of ARDS [14]. In this single-center study the ventilatory
strategies for CDS did not differ from those in other pa-
tients and were based on the same low tidal volume pro-
tocol. Recently it has been shown that apoptosis or pro-
grammed cell death plays a pivotal role in the pathogene-
sis of injurious states of the pulmonary system such as of
ALI/ARDS [15, 16]. The higher incidence of ALI/ARDS
may be caused by an elevated rate of apoptosis in CDS.
An enhanced level of apoptosis in DS has been shown in
several cells including neurons [17, 18], thymocytes [19],
and granulocytes[20]. It has been suggested that increased
apoptosis in DS cells is related to an inability to deal with
oxidative stress, leading to accumulation of reactive oxy-
gen radicals [21]. One could speculate whether this is re-
lated to an imbalance in the antioxidant/oxidant status in
patients with DS due to increased levels of superoxide dis-
mutase 1, an important enzyme in the antioxidant pathway
that is encoded for on chromosome 21 [22, 23]. To what
extent this is associated with an increased susceptibility to
develop ALI/ARDS deserves further investigation. From
this point of view our ﬁndings are not only of scientiﬁc in-
terest but may also be of clinical relevance. For example,
ventilatory strategies or oxygen therapy might need to be
reevaluated and adjusted for CDS.
In conclusion, we found an unexpected high incidence
of ALI and ARDS in CDS. The explanation for these ﬁnd-
ings remains to be elucidated.
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